These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 22170028)
21. A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: safety and immunity. Lu CC; Wang YC; Lai JH; Lee TS; Lin HT; Chang DM Vaccine; 2011 Jan; 29(3):444-50. PubMed ID: 21078406 [TBL] [Abstract][Full Text] [Related]
22. Immunogenicity of inactivated 2009 H1N1 influenza vaccine in pediatric liver transplant recipients. Torii Y; Kimura H; Ochi N; Kaneko K; Ando H; Kiuchi T; Ito Y Vaccine; 2011 Jun; 29(25):4187-9. PubMed ID: 21513762 [TBL] [Abstract][Full Text] [Related]
24. Immune response to 2009 pandemic H1N1 influenza virus A monovalent vaccine in children with cancer. Yen TY; Jou ST; Yang YL; Chang HH; Lu MY; Lin DT; Lin KH; Huang LM; Chang LY Pediatr Blood Cancer; 2011 Dec; 57(7):1154-8. PubMed ID: 21425448 [TBL] [Abstract][Full Text] [Related]
25. Immune response to pandemic H1N1 2009 influenza a vaccination in pediatric liver transplant recipients. Haller W; Buttery J; Laurie K; Beyerle K; Hardikar W; Alex G Liver Transpl; 2011 Aug; 17(8):914-20. PubMed ID: 21351241 [TBL] [Abstract][Full Text] [Related]
27. Acute encephalomyelitis syndromes associated with H1N1 09 influenza vaccination. Denholm JT; Neal A; Yan B; Petty S; Knox J; French C; Marshall C Neurology; 2010 Dec; 75(24):2246-8. PubMed ID: 21172848 [No Abstract] [Full Text] [Related]
28. Subunit influenza vaccines produced from cell culture or in embryonated chicken eggs: comparison of safety, reactogenicity, and immunogenicity. Reisinger KS; Block SL; Izu A; Groth N; Holmes SJ J Infect Dis; 2009 Sep; 200(6):849-57. PubMed ID: 19673652 [TBL] [Abstract][Full Text] [Related]
29. Influenza A/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months. Esposito S; Pugni L; Daleno C; Ronchi A; Valzano A; Serra D; Mosca F; Principi N Pediatrics; 2011 May; 127(5):e1161-8. PubMed ID: 21464195 [TBL] [Abstract][Full Text] [Related]
30. AS03(A)-Adjuvanted influenza A (H1N1) 2009 vaccine for adults up to 85 years of age. Roman F; Vaman T; Kafeja F; Hanon E; Van Damme P Clin Infect Dis; 2010 Sep; 51(6):668-77. PubMed ID: 20687838 [TBL] [Abstract][Full Text] [Related]
31. Relationship between intention of novel influenza A (H1N1) vaccination and vaccination coverage rate. Kwon Y; Cho HY; Lee YK; Bae GR; Lee SG Vaccine; 2010 Dec; 29(2):161-5. PubMed ID: 21055495 [TBL] [Abstract][Full Text] [Related]
32. Combined, concurrent, and sequential administration of seasonal influenza and MF59-adjuvanted A/H5N1 vaccines: a phase II randomized, controlled trial of immunogenicity and safety in healthy adults. Lopez P; Caicedo Y; Sierra A; Tilman S; Banzhoff A; Clemens R J Infect Dis; 2011 Jun; 203(12):1719-28. PubMed ID: 21606530 [TBL] [Abstract][Full Text] [Related]
33. Reactivation of acute retinal necrosis after flu H1N1 vaccination. Rothova A; de Groot JD; Mudrikova T Br J Ophthalmol; 2011 Feb; 95(2):291. PubMed ID: 20733030 [No Abstract] [Full Text] [Related]
35. Serious adverse reactions should be further monitored after influenza A (H1N1) vaccination among children: postmarketing experience with 570,000 vaccinations between October 2009 and August 2010 in Guangzhou, China. Fu C; Xu J; Tan H; Wang M Pediatr Infect Dis J; 2011 Jul; 30(7):631-2. PubMed ID: 21673552 [No Abstract] [Full Text] [Related]
36. [Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine]. Dong PM; Li YQ; Zheng TZ; Jia YP; Li F; Han TW; Qiao RX; Zhang BH Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul; 24(7):570-3. PubMed ID: 12975010 [TBL] [Abstract][Full Text] [Related]
37. Safety of influenza vaccination in patients with myasthenia gravis: a population-based study. Zinman L; Thoma J; Kwong JC; Kopp A; Stukel TA; Juurlink DN Muscle Nerve; 2009 Dec; 40(6):947-51. PubMed ID: 19902540 [TBL] [Abstract][Full Text] [Related]
38. Safety and immunogenicity of an inactivated split-virus influenza A/H1N1 vaccine in healthy children from 6 months to <18 years of age: a prospective, open-label, multi-center trial. Oh CE; Lee J; Kang JH; Hong YJ; Kim YK; Cheong HJ; Ahn YJ; Kim SH; Lee HJ Vaccine; 2010 Aug; 28(36):5857-63. PubMed ID: 20600483 [TBL] [Abstract][Full Text] [Related]
39. Utility of influenza vaccination for oncology patients. Pollyea DA; Brown JM; Horning SJ J Clin Oncol; 2010 May; 28(14):2481-90. PubMed ID: 20385981 [TBL] [Abstract][Full Text] [Related]
40. Diminished immunogenicity to pandemic H1N1 2009 influenza vaccine in subjects with severe motor and intellectual disability. Hara M; Hanaoka T; Mizushima T; Honma J; Maeda K; Ohfuji S; Tanaka K; Hirota Y Vaccine; 2011 Oct; 29(46):8323-9. PubMed ID: 21893146 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]